Overture Life key facts
as of Oct 2026- Developer of a reproduction automation technology designed to revolutionize embryology.
- Overture Life is valued at approximately $150.0M as of Oct 2026, set at its early-stage round, May 2021; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $81.2M across 1 recorded rounds; the latest was Early Stage VC ($13.6M) in Dec 2017.
- Notable investors include Mana Ventures, Khosla Ventures, GV, Felicis, Octopus Ventures — 19 tracked in total.
- Overture Life has filed 2 Form Ds with the SEC since 2017, most recently Dec 2018 ($13.6M sold to 10 investors).
- Status: Privately Held (backing).
Valued at $150.0M at its early-stage round, May 2021. Nothing has traded since.
- ·The complete investor list: 19 names
- ·Watch Overture Life: the Monday email on marks, rounds and moves
Overture Life funding rounds
1 roundsWho backs Overture Life
19+Overture Life valuation
Overture Life was valued at $150 million at its early-stage round in May 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Overture Life raised?
Overture Life has raised $81.2 million in total; 1 of its rounds is on record. The largest on record was a $13.6 million early-stage round in Dec 2017.
Overture Life has filed 2 Form Ds with the SEC since 2017, most recently in Dec 2018 ($13.6 million sold to 10 investors).
Overture Life investors
19 investors are on record for Overture Life, including Mana Ventures, Khosla Ventures, GV and Felicis. By type, the record holds 9 venture capital firms and 1 family office. The early-stage round in Dec 2017 drew 10 investors.
About Overture Life
Developer of a reproduction automation technology designed to revolutionize embryology. The company's technology is focused on the automation of in vitro fertilization, involving the commercialization of devices for automated cryopreservation, and offers a product that offers embryo testing and freezing services, enabling clinics to know which embryos are viable before implantation as well as help people to make babies.
- Sector
- Healthcare
- HQ
- Alcobendas, Spain
- Founded
- 2017
- Employees
- 37
- Website
- overture.life/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.